Bioretec Oy
OMXH:BRETEC
Balance Sheet
Balance Sheet Decomposition
Bioretec Oy
Bioretec Oy
Balance Sheet
Bioretec Oy
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1
|
0
|
2
|
7
|
1
|
7
|
6
|
4
|
|
| Cash Equivalents |
1
|
0
|
2
|
7
|
1
|
7
|
6
|
4
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
0
|
1
|
1
|
1
|
1
|
2
|
4
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
1
|
3
|
8
|
3
|
9
|
10
|
9
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
2
-34%
|
4
+138%
|
9
+120%
|
3
-59%
|
11
+206%
|
11
+8%
|
12
+2%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
2
|
1
|
1
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Total Current Liabilities |
0
|
1
|
1
|
4
|
1
|
2
|
1
|
2
|
|
| Long-Term Debt |
2
|
2
|
2
|
0
|
1
|
1
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
3
+19%
|
3
-13%
|
4
+68%
|
2
-63%
|
2
+55%
|
2
-28%
|
2
+10%
|
|
| Equity | |||||||||
| Common Stock |
9
|
9
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Retained Earnings |
9
|
10
|
3
|
1
|
2
|
4
|
6
|
6
|
|
| Other Equity |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
1
N/A
|
1
N/A
|
4
+219%
|
2
-56%
|
8
+328%
|
10
+18%
|
10
+0%
|
|
| Total Liabilities & Equity |
2
N/A
|
2
-34%
|
4
+138%
|
9
+120%
|
3
-59%
|
11
+206%
|
11
+8%
|
12
+2%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
13
|
13
|
13
|
14
|
15
|
20
|
24
|
31
|
|